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Dear Editor,
Celiac disease (CD) is an autoimmune disorder characterized 
by small intestinal mucosal injury and nutrient malabsorption 
that affects patients with a specific genetic predisposition (HLA 
DR3-DQ2 and HLA DR4-DQ8) who are exposed to gluten, the ma-
jor storage protein of wheat and similar grains (1, 2). Abnormal 
immune response to gliadin, genetic factors, and environmen-
tal factors play a role in the pathogenesis of CD. Infectious agents 
have been implicated in the pathogenesis of many autoimmune 
disorders. Transient infections or increased permeability of the 
mucosa may facilitate disease onset induced by the uptake of 
gluten peptides into a microenvironmental milieu in the small 
intestinal mucosa (3). An environmental factor, such as an in-
fectious agent, is thought to precipitate the disease via various 
pathogenic mechanisms, such as molecular mimicry, resulting 
in modulation of the host’s immune tolerance (2). Recently, the 
literature has reported on two patients who experienced an on-
set of CD after resolution of acute hepatitis B virus (HBV) infec-
tion (3). CD has also been described in association with hepatitis 
C virus (HCV), rota virus, and adenovirus 12 as other immunolog-
ic manifestations of this infectious disease (4-6). In the study by 
Leonardi and La Rosa (2010), which examined the possibility of 
HBV and its linkage with CD (7). CD is more common in individ-
uals with HLA DQ2 and HLA DQ8, and the literature has shown 
that these individuals have a lower response rate to HBV vac-
cination (50%-68%) than the general population (4%-10%; (8-11)). 
Recently, Ertem et al. (2010) examined the response to HBV vac-
cine prospectively in a group of CD patients and explored the 
potential link between CD and HBV-vaccine nonresponsiveness 
by studying shared HLA haplotypes. In their study they found 
that the response to HBV vaccine in celiac children who were 
compliant with a gluten-free diet (GFD) was not different from 
the response in a healthy population. CD may be one of the im-
mune diseases associated with a high rate of HBV vaccine non-
responsiveness, but it might not be permanent, and treatment 
with GFD and compliance with the treatment may ameliorate 
the lack of responsiveness to the HBV vaccine in celiac children 
(12). Therefore, nonresponsiveness to the HBV vaccine may be 
a sign of undiagnosed CD (9). These findings provide useful 
information to reassess current vaccination strategies; in par-
ticular, revaccination is recommended during a controlled GFD 
(8). Leonardi and La Rosa (2010)’s findings on the prevalence of 
CD in chronic HBV carrier patients is not conclusive given that 
only a few patients tested positive for IgG-AGA and IgA-AGA and 
none of the patients tested positive for IgA-EmA or IgA-tTGA. The 
prevalence of CD in the normal population of that area is not 
mentioned or compared in that study. Thus, the role of HBV as a 
triggering factor for CD seems to be a remote possibility. Activa 
tion of CD during interferon (IFN-α) therapy for hepatitis-virus 
infection is also a point of discussion. In the study by Leonardi 
and La Rosa (2010), none of the IFN-α–treated patients had any 
serological marker of CD (7). CD has been epidemiologically 
associated with chronic hepatitis C and CD activation after the 
initiation of IFN-α in patients with HCV. However, a clear associa-
tion of CD and HCV is lacking (13-15). CD prevalence is not higher 
in patients with HCV. Routine screening of CD in HCV patients 
is not warranted; however, the presence of CD should be con-
sidered in the context of clinical deterioration during or after 
IFN- α therapy (15). Plot et al. (2009) examined the association 
between serological evidence of past infection with Toxoplasma 
gondii, rubella virus, cytomegalovirus, Treponema pallidum, 
and Epstein-Barr virus and the coexistence of CD. The results 
implied that certain infections may generate an immunological 
environment that disfavors the future appearance of certain au-
toimmune conditions such as CD (16). Therefore, understanding 
the relationship between infectious agents and autoimmune 
disorders is of utmost importance and may assist in the predic-
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tion, early diagnosis, and perhaps also the prevention of CD (2). 
With the available evidence to date, it is difficult to establish a 
link between HBV, other viruses, and CD.  Several isolated cases 
of infection with HBV and other viruses, which probably only re-
flect a fortuitous association with CD, have been cited in the lit-
erature. However, further studies are needed to explore whether 
a link between viral infection and CD really does exist.
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